AbbVie, Merck, Pfizer, UCB sales and marketing update

The U.K.’s NICE issued final guidance recommending five compounds that target tumor necrosis factor (TNF) alpha to treat ankylosing spondylitis and non-radiographic axial spondyloarthritis in adults ...